Welcome to our dedicated page for Butterfly Network SEC filings (Ticker: BFLY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Locating the right numbers in Butterfly Network Inc.’s dense filings can feel harder than mastering an ultrasound scan itself. The company’s mix of device sales, subscription software, and FDA-regulated innovation packs its 10-K with complex revenue recognition notes and R&D breakouts that few have time to untangle.
Stock Titan’s AI steps in as your diagnostic tool. Our platform streams every Butterfly Network quarterly earnings report 10-Q filing, 8-K material events explained, and Form 4 insider transactions in real time straight from EDGAR, then delivers plain-English summaries, variance tables, and alert triggers. Want the cash-burn trend without wading through footnotes? Curious how executive stock grants shift in the proxy? Our AI highlights the exact pages, answers common questions like “understanding Butterfly Network SEC documents with AI,” and links directly to the source paragraph for fast verification.
Whether you’re monitoring Ultrasound-on-Chip production costs, checking Butterfly Network insider trading Form 4 transactions before earnings, or comparing subscription margins across periods, you’ll find every filing type here—10-K, 10-Q, 8-K, 4, S-1, 14A—updated the moment the company files. Analysts use our insights to:
- Track segment revenue growth across devices and SaaS
- Spot FDA-related disclosures hidden in 8-Ks
- Compare executive compensation in the latest proxy statement
Skip the page-flipping and focus on decisions. Our AI-powered analysis makes Butterfly Network annual report 10-K simplified, keeps you on top of Butterfly Network executive stock transactions Form 4, and answers, in seconds, what used to take hours.
Butterfly Network, Inc. insider activity shows a director and 10% owner reporting sales of Class A common stock. On December 8, 2025, entities associated with the reporting person sold 543,601 Class A shares and 225,726 Class A shares at a weighted average price of $3.2727 per share. On December 9, 2025, an associated entity sold an additional 176,070 Class A shares at a weighted average price of $3.1054 per share. The filing states these transactions were made under a Rule 10b5-1 trading plan adopted on March 5, 2025 for estate planning purposes. After these sales, the reporting person continues to hold indirect beneficial ownership in Class A and Class B shares through multiple LLC and trust entities.
Butterfly Network Inc. shareholder Dr. Jonathan Rothberg filed a Form 144 notice to sell up to 288,918 shares of common stock through Jefferies on the NYSE around 12/10/2025. The shares to be sold have an indicated aggregate market value of $905,237.00, compared with 226,200,000 shares of common stock outstanding.
These shares were originally acquired on 08/31/2014 via a private purchase from Butterfly Network Inc. for cash. The filing also lists multiple recent sales of the company’s common stock by Dr. Rothberg during the prior three months, including 1,110,579 shares sold on 11/24/2025 for gross proceeds of $3,503,032.70. By signing, the seller represents that he is not aware of undisclosed material adverse information about the company.
Butterfly Network, Inc. (BFLY) reported an equity award to its Executive Vice President and Chief Financial Officer in the form of restricted stock units (RSUs) on December 8, 2025. The officer received 863,247 RSUs, each convertible into one share of Class A common stock, with one-third vesting on December 8, 2026 and the rest vesting annually over the following two years, subject to continued service.
The officer also received 431,623 performance-based RSUs. These vest in three equal tranches if the stock price reaches or exceeds $3.00, $4.50, and $6.00 per share, respectively, for 20 consecutive trading days before December 8, 2030, and if the officer remains in service through each vesting date. The reported acquisition price for the RSUs is $0 as they are part of compensation.
Butterfly Network, Inc. executive reports no share ownership. An executive vice president and chief financial officer of Butterfly Network, Inc. filed an initial beneficial ownership statement as an officer of the company. The filing indicates that no Butterfly Network securities are currently beneficially owned, as explicitly stated in the remarks section.
Butterfly Network insider Dr. Jonathan Rothberg filed a notice to sell 176,070 shares of common stock. The shares are to be sold through Jefferies on the NYSE, with an approximate sale date of December 9, 2025, and an indicated aggregate market value of
The shares being sold were originally acquired on August 31, 2014, in a private purchase from Butterfly Network, Inc., paid in cash. The filing also discloses that over the past three months Dr. Rothberg has already sold multiple blocks of common stock, including 1,110,579 shares on November 24, 2025 for gross proceeds of
Butterfly Network, Inc. insider Jonathan M. Rothberg, Ph.D., a director and 10% owner, reported planned stock sales under a Rule 10b5-1 trading plan. The plan was adopted on March 5, 2025 for estate planning purposes.
On December 4, 2025, an affiliated entity, GBR TR, LLC, sold 64,198 shares of Class A common stock at a weighted average price of $3.076 per share, leaving 581,199 Class A shares indirectly held by that entity. On December 5, 2025, GBR TR, LLC sold an additional 37,598 Class A shares at a weighted average price of $3.0744, with 543,601 Class A shares remaining indirectly held.
Rothberg reports indirect beneficial ownership of additional Class A and Class B common stock through multiple family trusts and holding companies and disclaims beneficial ownership beyond his pecuniary interest.
Butterfly Network insider Dr. Jonathan Rothberg filed a notice of proposed sale of 769,327 shares of the company’s common stock. The shares are to be sold through broker Jefferies on the NYSE, with an aggregate market value of
The shares were originally acquired on
Butterfly Network, Inc. director and 10% owner Larry Robbins reported a series of open-market purchases of Class A common stock. On December 3, 2025, entities he oversees bought 821,648 shares at a weighted average price of $2.9619 per share. On December 4, 2025, they bought 536,893 shares at a weighted average of $2.9947, and on December 5, 2025, they bought 200,000 shares at a weighted average of $3.0565.
The shares were acquired by Glenview investment funds, for which Robbins is investment manager, and he shares voting and dispositive power over these holdings. He also has interests through Longview Investors LLC and holds additional securities, including restricted stock units that vest at the company’s 2026 annual stockholders meeting, conditioned on his continued board service.
Butterfly Network insider Dr. Jonathan Rothberg has filed a Form 144 notice to sell 37,598 shares of the company’s common stock through broker Jefferies on the NYSE, with an aggregate market value of $115,591.00. The notice states that 226,200,000 shares of common stock were outstanding, providing a baseline for the company’s total share count.
The shares to be sold were originally acquired on 08/31/2014 in a private purchase from Butterfly Network Inc., paid in cash. The filing also lists prior sales over the past three months, including 100,502 shares sold on 11/03/2025 for gross proceeds of $309,361.24 and 1,110,579 shares sold on 11/24/2025 for $3,503,032.70, along with several additional transactions in late November and early December 2025.
Butterfly Network Inc. insider Dr. Jonathan Rothberg has filed a Form 144 indicating an intention to sell 64,198 shares of the company’s common stock through broker Jefferies on the NYSE, with an approximate sale date of 12/04/2025. These shares were originally acquired on 08/31/2014 via a private purchase from Butterfly Network Inc. for cash. The filing also lists several recent sales of Butterfly Network common stock by Dr. Rothberg during November 2025, each with disclosed share amounts and gross proceeds.